BOH
ALXN

Bank of Hawaii’s Alexion Pharmaceuticals ALXN Stock Holding History

Bank of Hawaii’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,575
Closed -$1.47M – 337
2019
Q4 		$1.47M Buy
13,575
+9,360
+222% +$1M 0.1% 121
2019
Q3 		$413K Buy
+4,215
New +$475K 0.03% 257
2014
Q3 		– Sell
-1,584
Closed -$247K – 386
2014
Q2 		$247K Sell
1,584
-31
-2% -$4.89K 0.02% 310
2014
Q1 		$246K Buy
+1,615
New +$257K 0.02% 308

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Bank of Hawaii's ALXN Position: Q1 2020 in Review

Bank of Hawaii sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 13,575 shares — an estimated $1.47M sold.

Bank of Hawaii first reported a position in ALXN in Q1 2014 and held it in 4 quarters. The position peaked at $1.47M in Q4 2019. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Bank of Hawaii reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Bank of Hawaii sold 13,575 Alexion Pharmaceuticals shares in Q1 2020, an estimated $1.47M.
  • Bank of Hawaii first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Bank of Hawaii's Alexion Pharmaceuticals position peaked at $1.47M in Q4 2019.
  • 654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Bank of Hawaii's 13F filing for Q1 2020, filed 13 May 2020.